Rochester, NY (PRWEB) November 20, 2013 -- A recent study found that statins damage the immune system, which in turn, can cause the reactivation of latent viruses. The study was published on November 13, 2013 in the medical journal Clinical Infectious Diseases (1). “Statins are widely used lipid-lowering drugs with immunomodulatory properties that may favour reactivation of latent…virus infection (1). What happens when latent viruses are reactivated? The answer is disease processes, including diabetes (2), Alzheimer’s disease (3), and cancer (4). In other words these patients trade heart disease with other life ending diseases.
It is well known that, like all drugs, statins have side effects. One such side effect is myopathy (muscle disease). Another side effect is a weakened immune system. A weakened immune system can reactivate latent viruses and cause disease. Another study found that statins specifically harm the ability of immune T-cells to activate. “Statins impair T cell activation directly.” That study was published on October 13, 2009 in the Journal of Leukocyte Biology (5). T-cells are white blood cells that are an essential part of the immune system.
According to Dr. Michael Roizen in an online question and answer forum on ShareCare.com, “15 million Americans are now taking a statin drug (6).”
The Center for the Biology of Chronic Disease is confident that as the rate of statin use rises, so shall diseases caused by latent viruses. The Center therefore recommends that doctors learn about natural, antiviral remedies proven to lower symptoms associated with latent viral infections, like Gene-Eden-VIR. These natural remedies can be prescribed together with statins to help mitigate the effect of a weakened immune system on latent viruses.
In a post marketing clinical study published on August 12, 2013 in the medical journal Pharmacology & Pharmacy in a special edition on Advances in Antiviral Drugs, researchers showed that Gene-Eden-VIR is safe and effective (7). Additionally, up to 70% of those studied reported a decrease in viral symptoms, and users experienced an increase in overall health (7).
To read the full study on Gene-Eden-VIR, visit http://gene-eden-kill-virus.com/PP_Gene-Eden-VIR-is-Antiviral.pdf.
To learn about the CBCD and research concerning latent viruses, please visit http://www.cbcd.net.
To schedule an interview with a CBCD official, E-mail info (at)buy-gene-eden(dot)com or phone 585-250-9999.
(1) Statins and the risk of herpes zoster: a population-based cohort study. Published November 13, 2013
(2) Type 1 Caused, Reviewed May 2013
(3) Neurological complications of herpes simplex virus type 2 infection. May 2008
(4) Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr virus. September 12, 2013
(5) Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus. Published October 13, 2009
(6) How many people take statin drugs? 2013
(7) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published August 12, 2013
The CBCD is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.
The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.
Hanan Polansky, Center for the Biology of Chronic Disease (CBCD), +1 (585) 250-9999, [email protected]
SOURCE Center for the Biology of Chronic Disease (CBCD)